Das
#VACCELERATE Freiwilligenregister sucht Teilnehmende für eine klinische Studie zu einem noch nicht zugelassenen Medikament für die Behandlung von
#Herpes.
https://www.hsvclinicaltrial.com/german-de/home---dePRIOH-1 | Herpes-simplex-Virus | Erfahren Sie mehr
Wenn Sie ein geschwächtes Immunsystem haben und aufgrund des Herpes-simplex-Virus an Läsionen leiden, prüfen Sie, ob Sie für die PRIOH-1-Studie infrage kommen.
RT VACCELERATE Consortium 🇪🇺🇺🇦
Do not forget to register 👇: https://uni-koeln.zoom.us/meeting/register/tJwpdOuvrTksEt27nOEBhVDAiVUz5AKRuKK-
@EU_HaDEA @UKKoeln @UniCologne @CECAD_
<div class="rsshub-quote">
VACCELERATE Consortium 🇪🇺🇺🇦: Last #VACCELERATE webinar before the summer break:
#eConsent - Chances and Challenges for a Multistakeholder Community with @hvanaken_hilde @EFGCP @ECRIN_ERIC.
05 July, 14.00 CEST
Participation free of charge. Registration: https://uni-koeln.zoom.us/meeting/register/tJwpdOuvrTksEt27nOEBhVDAiVUz5AKRuKK- https://t.co/eRlZAUjfZ9
</div>
🐦🔗: https://n.respublicae.eu/vaccelerate_eu/status/1673617505535811584
Welcome! You are invited to join a meeting: VACCELERATE Webinar: eConsent-Chances and challenges for a multistakeholder community. After registering, you will receive a confirmation email about joining the meeting.
Welcome! You are invited to join a meeting: VACCELERATE Webinar: eConsent-Chances and challenges for a multistakeholder community. After registering, you will receive a confirmation email about joining the meeting.
VACCELERATE: A European network, Kerstin Albus, ECCMID 2023
RT @vaccelerate_eu: Just in time for lunch🍝🍜:
Our #VACCELERATE 🆕news with study updates, events, volunteer numbers, communication news and the announcement of our next webinar.
Enjoy reading ! 📰 https://t.co/gumEFeInYT
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1668614952209494023
VACCELERATE Consortium 🇪🇺🇺🇦 on Twitter
“Just in time for lunch🍝🍜:
Our #VACCELERATE 🆕news with study updates, events, volunteer numbers, communication news and the announcement of our next webinar.
Enjoy reading ! 📰”
RT @vaccelerate_eu: #Vacuna @quambene @tobiasherion helps you keep track of your vaccination status.
The countdown ⏱️ is on for our #VACCELERATE collaboration with the vaccination app 📱💉. You can expect many benefits if you register in our #VolunteerRegistry 🧑🤝🧑.
More details will follow soon... https://t.co/YTD4pIezzB
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1651177457301569537
VACCELERATE Consortium 🇪🇺🇺🇦 on Twitter
“#Vacuna @quambene @tobiasherion helps you keep track of your vaccination status.
The countdown ⏱️ is on for our #VACCELERATE collaboration with the vaccination app 📱💉. You can expect many benefits if you register in our #VolunteerRegistry 🧑🤝🧑.
More details will follow soon...”
RT @vaccelerate_eu: Our #VACCELERATE topics for the #ECCMID2023 final spurt: #ResearchNurses, #MAK5, #VolunteerRegistry #BeTheMissingPiece.
We are looking forward to a lively exchange and an exciting last day!
@Fiona_Cologne @JuliaNacov @SalmantonGarcia
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1647984774978338820
HaDEA (@EU_HaDEA)
RT @vaccelerate_eu: Our #VACCELERATE topics for the #ECCMID2023 final spurt: #ResearchNurses, #MAK5, #VolunteerRegistry #BeTheMissingPiece.…
RT @vaccelerate_eu: For your day planning at #ECCMID2023 in Copenhagen tomorrow 👇.
We would be very happy to talk to you about #VACCELERATE, #COVID19, #clinicaltrials, our #VolunteerRegistry and the #SiteNetwork.
#BeTheMissingPiece
@VaccelerateCY @SalmantonGarcia @JuliaNacov
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1647860729859416065
HaDEA (@EU_HaDEA)
RT @vaccelerate_eu: For your day planning at #ECCMID2023 in Copenhagen tomorrow 👇.
We would be very happy to talk to you about #VACCELERAT…
RT @vaccelerate_eu: Visiting #ECCMID2023 in Copenhagen, April 15th -18th?
Don't miss out on visiting us in the Poster Arena on 17th and 18th - Very excited to meet you in Denmark and looking forward to informing you about #VACCELERATE.
@EU_HaDEA
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1646797179783184385
HaDEA (@EU_HaDEA)
RT @vaccelerate_eu: Visiting #ECCMID2023 in Copenhagen, April 15th -18th?
Don't miss out on visiting us in the Poster Arena on 17th and 18t…
Welcome! You are invited to join a meeting: VACCELERATE Webinar: Clinical Trials on Chronic Fatigue Syndrome and Post-COVID Syndrome. After registering, you will receive a confirmation email about joining the meeting.
Clinical Trials on Chronic Fatigue Syndrome (ME/CFS) and Post-COVID Syndrome
With Prof. Carmen Scheibenbogen, Charité Berlin, Germany
The Post-COVID Syndrome (PCS) can vary greatly in severity, but is usually accompanied by severe fatigue. Some of those affected suffer from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Knowledge about targeted therapies for both conditions is still in its infancy. Little is known about the exact disease mechanisms of ME/CFS and Post-COVID syndrome. Therefore, no targeted medical treatments exist. As a result, many people with ME/CFS are perpetually ill and unable to work or to take care of their families. Researchers at Charité - Universitätsmedizin Berlin have now founded a National Clinical Study Group to conduct the first clinical trials with drugs for the treatment of PCS and ME/CFS.
Prof. Scheibenbogen's study group wants to initiate and conduct first clinical trials with drugs and medical procedures for PCS and ME/CFS. The aim is to receive approval for effective therapies to make them available to all patients. The focus is on drugs that are already available for other diseases to achieve rapid progress in treatment.
In this webinar, Prof. Scheibenbogen introduces the study group and its goals. She will explain how the process of enrolling patients and conducting the studies is planned and when first results can be expected.
Willingness to participate in COVID-19 vaccine trials
Speckdäne
HaDEA